These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 29408481)
21. High expression of microRNA-4295 contributes to cell proliferation and invasion of pancreatic ductal adenocarcinoma by the down-regulation of Glypican-5. Yuan Q; Zhang Y; Li J; Cao G; Yang W Biochem Biophys Res Commun; 2018 Feb; 497(1):73-79. PubMed ID: 29407175 [TBL] [Abstract][Full Text] [Related]
22. Tumor suppressive role of miR-33a-5p in pancreatic ductal adenocarcinoma cells by directly targeting RAP2A. Lian Y; Jiang D; Sun J Cell Mol Biol Lett; 2021 Jun; 26(1):24. PubMed ID: 34090323 [TBL] [Abstract][Full Text] [Related]
23. ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma. Yonemori K; Seki N; Kurahara H; Osako Y; Idichi T; Arai T; Koshizuka K; Kita Y; Maemura K; Natsugoe S Cancer Sci; 2017 Jan; 108(1):124-135. PubMed ID: 27862697 [TBL] [Abstract][Full Text] [Related]
24. Exosomes secreted from human umbilical cord mesenchymal stem cells promote pancreatic ductal adenocarcinoma growth by transferring miR-100-5p. Ding Y; Mei W; Zheng Z; Cao F; Liang K; Jia Y; Wang Y; Liu D; Li J; Li F Tissue Cell; 2021 Dec; 73():101623. PubMed ID: 34543801 [TBL] [Abstract][Full Text] [Related]
25. Identifying a novel IRF3/circUHRF1/miR-1306-5p/ARL4C axis in pancreatic ductal adenocarcinoma progression. Liu W; Deng L; Xu A; Xiong X; Tao J; Chang J; Xu Y; Zhou Z Cell Cycle; 2022 Feb; 21(4):392-405. PubMed ID: 34983293 [TBL] [Abstract][Full Text] [Related]
26. Role of miR-214-5p in the migration and invasion of pancreatic cancer cells. Cao TH; Ling X; Chen C; Tang W; Hu DM; Yin GJ Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7214-7221. PubMed ID: 30468464 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4. Xia X; Zhang K; Cen G; Jiang T; Cao J; Huang K; Huang C; Zhao Q; Qiu Z Oncotarget; 2015 Aug; 6(25):21046-63. PubMed ID: 26019136 [TBL] [Abstract][Full Text] [Related]
28. Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathway. Liu L; Liu FB; Huang M; Xie K; Xie QS; Liu CH; Shen MJ; Huang Q Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):580-586. PubMed ID: 30898507 [TBL] [Abstract][Full Text] [Related]
29. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion. He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622 [TBL] [Abstract][Full Text] [Related]
30. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3. Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830 [TBL] [Abstract][Full Text] [Related]
31. miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I. Song B; Ji W; Guo S; Liu A; Jing W; Shao C; Li G; Jin G FEBS Lett; 2014 Nov; 588(23):4375-81. PubMed ID: 25315416 [TBL] [Abstract][Full Text] [Related]
32. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Ding Y; Cao F; Sun H; Wang Y; Liu S; Wu Y; Cui Q; Mei W; Li F Cancer Lett; 2019 Feb; 442():351-361. PubMed ID: 30419348 [TBL] [Abstract][Full Text] [Related]
33. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes. Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387 [TBL] [Abstract][Full Text] [Related]
35. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC. Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-135a inhibits cell proliferation by targeting Bmi1 in pancreatic ductal adenocarcinoma. Dang Z; Xu WH; Lu P; Wu N; Liu J; Ruan B; Zhou L; Song WJ; Dou KF Int J Biol Sci; 2014; 10(7):733-45. PubMed ID: 25013381 [TBL] [Abstract][Full Text] [Related]
37. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343 [TBL] [Abstract][Full Text] [Related]
38. Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. Zhao C; Zhang J; Zhang S; Yu D; Chen Y; Liu Q; Shi M; Ni C; Zhu M Oncol Rep; 2013 Jul; 30(1):276-84. PubMed ID: 23612862 [TBL] [Abstract][Full Text] [Related]
39. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma. Wei DM; Dang YW; Feng ZB; Liang L; Zhang L; Tang RX; Chen ZM; Yu Q; Wei YC; Luo DZ; Chen G Cell Physiol Biochem; 2018; 50(3):823-840. PubMed ID: 30355917 [TBL] [Abstract][Full Text] [Related]
40. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway. Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]